Surmodics Battles Cyberattack as IT Systems Remain Under Siege
The Record
|
Contributed by: Drex DeFord
Summary
Surmodics, a leading provider of hydrophilic coatings for intravascular medical devices, suffered a significant cyberattack on June 5, prompting a partial shutdown of its IT systems. This incident is notable as it marks Surmodics as the third publicly traded medical device company to report a cyberattack to the SEC in recent months, indicating a troubling trend in the industry. While the company has started to recover with the help of cybersecurity experts, the ongoing investigation highlights potential risks such as litigation, regulatory scrutiny, and shifts in customer confidence. As healthcare technology increasingly integrates digital systems, these incidents underscore the need for robust cybersecurity measures to protect sensitive information and maintain operational continuity.
